Ali A, Zafar H, Zia M, et al (2016) Synthesis, characterization, applications, and challenges of iron oxide nanoparticles. Nanotechnol Sci App 9:49–67. https://doi.org/10.2147/NSA.S99986
Alkilani AZ, McCrudden MTC, Donnelly RF (2015) Transdermal Drug Delivery: Innovative Pharmaceutical Developments Based on Disruption of the Barrier Properties of the stratum corneum. Pharmaceutics 7:438–470
Alvarez-Roman R, Merino G, Kalia YN, et al (2003) Skin permeability enhancement by low frequency sonophoresis: lipid extraction and transport pathways. J Pharm Sci 92:1138–46
Anandhakumar S, Raichur AM (2013) Polyelectrolyte/silver nanocomposite multilayer films as multifunctional thin film platforms for remote activated protein and drug delivery. Acta Biomater 9:8864–8874
Barenholz Y (2012) Doxil(R)–the first FDA-approved nano-drug: lessons learned. J Control Release 160:117–34
Baroli B, Ennas MG, Loffredo F, et al (2007) Penetration of Metallic Nanoparticles in Human Full-Thickness Skin. J Invest Dermatol 127:1701–1712. https://doi.org/10.1038/sj.jid.5700733
Bryce NS, Pham BTT, Fong NWS, et al (2013) The composition and end-group functionality of sterically stabilized nanoparticles enhances the effectiveness of co-administered cytotoxins. Biomater Sci 1:1260–1272. https://doi.org/10.1039/C3BM60120J
Carter P, Narasimhan B, Wang Q (2019) Biocompatible nanoparticles and vesicular systems in transdermal drug delivery for various skin diseases. Int J Pharm 555:49–62. https://doi.org/10.1016/j.ijpharm.2018.11.032
Cazares-Delgadillo J, Naik A, Ganem-Rondero A, et al (2007) Transdermal delivery of cytochrome C–A 12.4 kDa protein–across intact skin by constant-current iontophoresis. Pharm Res 24:1360–8
Chaudhuri P, Soni S, Sengupta S (2010) Single-walled carbon nanotube-conjugated chemotherapy exhibits increased therapeutic index in melanoma. Nanotechnology 21:025102
Chen G, Li D, Li J, et al (2015) Targeted doxorubicin delivery to hepatocarcinoma cells by lactobionic acid-modified laponite nanodisks. New J. Chem. 39:2847–2855
Dianzani C, Zara GP, Maina G, et al (2014) Drug delivery nanoparticles in skin cancers. Biomed Res Int 2014:895986
Eamegdool SS, Weible MW, Pham BTT, et al (2014) Ultrasmall superparamagnetic iron oxide nanoparticle prelabelling of human neural precursor cells. Biomaterials 35:5549–5564. https://doi.org/10.1016/j.biomaterials.2014.03.061
Fang J-Y, Hung C-F, Fang Y-P, Chan T-F (2004) Transdermal iontophoresis of 5-fluorouracil combined with electroporation and laser treatment. Int J Pharm 270:241–249
Fernandes R, Smyth NR, Muskens OL, et al (2015) Interactions of Skin with Gold Nanoparticles of Different Surface Charge, Shape, and Functionality. Small 11:713–721
Galluzzi L, Buqué A, Kepp O, et al (2015) Immunological Effects of Conventional Chemotherapy and Targeted Anticancer Agents. Cancer Cell 28:690–714. https://doi.org/10.1016/j.ccell.2015.10.012
Garbe C, Eigentler TK, Keilholz U, et al (2011) Systematic review of medical treatment in melanoma: current status and future prospects. Oncologist 16:5–24
Gautam A, Nanda JS, Samuel JS, et al (2016) Topical Delivery of Protein and Peptide Using Novel Cell Penetrating Peptide IMT-P8. Sci. Rep. 6:26278
Hansen S, Lehr C-M (2012) Nanoparticles for transcutaneous vaccination. Microb. Biotechnol. 5:156–167
Hasany S, Rehman A, Ahmed I, Rajan J (2012) Systematic review of the preparation techniques of iron oxide magnetic nanoparticles. Nanosci Nanotechnol 2(6):148–158
Herndon TO, Gonzalez S, Gowrishankar TR, et al (2004) Transdermal microconduits by microscission for drug delivery and sample acquisition. BMC Med 2:12
Hsiao PF, Peng S, Tang TC, et al (2016) Enhancing the in vivo transdermal delivery of gold nanoparticles using poly(ethylene glycol) and its oleylamine conjugate. Int J Nanomedicine 11:1867–78
Jain N, Wang Y, Jones SK, et al (2010) Optimized steric stabilization of aqueous ferrofluids and magnetic nanoparticles. Langmuir 26:4465–72
Kievit FM, Wang FY, Fang C, et al (2011) Doxorubicin loaded iron oxide nanoparticles overcome multidrug resistance in cancer in vitro. J. Controlled Release 152:76–83
Kotiyan P, Majali A., Vavia P, Bhardwaj Y, Sabarwal S A (2004) Electronbeam irradiation: a novel technology for the development oftransdermal system of isosorbide dinitrate. Int J Pharm 270 (1)
Lohade AA, Jain RR, Iyer K, et al (2016) A Novel Folate-Targeted Nanoliposomal System of Doxorubicin for Cancer Targeting. AAPS PharmSciTech 17:1298–1311. https://doi.org/10.1208/s12249-015-0462-2
Lombry C, Dujardin N, Preat V (2000) Transdermal delivery of macromolecules using skin electroporation. Pharm Res 17:32–7
Lv Q, He C, Quan F, et al (2017) DOX/IL-2/IFN-γ co-loaded thermo-sensitive polypeptide hydrogel for efficient melanoma treatment. Bioact. Mater. 3:118–128
Massart R, Dubois E, Cabuil V, Hasmonay E (1995) Preparation and Properties of Monodisperse Magnetic Fluids. J. Magn. Magn. Mater. 149:1–5
Matsui T, Amagai M (2015) Dissecting the formation, structure and barrier function of the stratum corneum. Int Immunol 27:269–280. https://doi.org/10.1093/intimm/dxv013
Mulens-Arias V, Rojas JM, Sanz-Ortega L, et al (2019) Polyethylenimine-coated superparamagnetic iron oxide nanoparticles impair in vitro and in vivo angiogenesis. Nanomedicine Nanotechnol Biol Med 21:102063. https://doi.org/10.1016/j.nano.2019.102063
Mundra V, Li W, Mahato RI (2015) Nanoparticle-mediated drug delivery for treating melanoma. Nanomed. 10:2613–2633
Murthy SN, Sammeta SM, Bowers C (2010) Magnetophoresis for enhancing transdermal drug delivery: Mechanistic studies and patch design. J Control Release 148:197–203
Nose K, Pissuwan D, Goto M, et al (2012) Gold nanorods in an oil-base formulation for transdermal treatment of type 1 diabetes in mice. Nanoscale 4:3776–80
Oh JM, Park DH, Choi SJ, Choy JH (2012) LDH nanocontainers as bio-reservoirs and drug delivery carriers. Recent Pat Nanotechnol 6:200–17
Ozcan A, Sahin D, Impellizzieri D, et al (2020) Nanoparticle-Coupled Topical Methotrexate Can Normalize Immune Responses and Induce Tissue Remodeling in Psoriasis. J Invest Dermatol 140:1003-1014 e8
Palanisamy S, Wang YM (2019) Superparamagnetic iron oxide nanoparticulate system: synthesis, targeting, drug delivery and therapy in cancer. Dalton Trans 48:9490–9515
Palmer BC, DeLouise LA (2016) Nanoparticle-Enabled Transdermal Drug Delivery Systems for Enhanced Dose Control and Tissue Targeting. Molecules 21:1719. https://doi.org/10.3390/molecules21121719
Pan J, Rostamizadeh K, Filipczak N, Torchilin VP (2019) Polymeric Co-Delivery Systems in Cancer Treatment: An Overview on Component Drugs’ Dosage Ratio Effect. Mol. Basel Switz. 24:1035
Pelaz B, Alexiou C, Alvarez-Puebla RA, et al (2017) Diverse Applications of Nanomedicine. ACS Nano 11:2313–2381. https://doi.org/10.1021/acsnano.6b06040
Pham BT, Jain N, Kuchel PW, et al (2015) The interaction of sterically stabilized magnetic nanoparticles with fresh human red blood cells. In: Int. J. Nanomedicine. https://www.dovepress.com/the-interaction-of-sterically-stabilized-magnetic-nanoparticles-with-f-peer-reviewed-article-IJN. Accessed 15 Jun 2020
Pham BTT, Colvin EK, Pham NTH, et al (2018) Biodistribution and Clearance of Stable Superparamagnetic Maghemite Iron Oxide Nanoparticles in Mice Following Intraperitoneal Administration. Int J Mol Sci 19
Pham TN, Lengkeek NA, Greguric I, et al (2017) Tunable and noncytotoxic PET/SPECT-MRI multimodality imaging probes using colloidally stable ligand-free superparamagnetic iron oxide nanoparticles. Int J Nanomedicine 12:899–909. https://doi.org/10.2147/IJN.S127171
Prausnitz MR (2004) Microneedles for transdermal drug delivery. Adv Drug Deliv Rev 56:581–7
Prausnitz MR, Langer R (2008) Transdermal drug delivery. Nat Biotechnol 26:1261–8. https://doi.org/10.1038/nbt.1504
Rao Y, Chen W, Liang X, et al (2015) Epirubicin-Loaded Superparamagnetic Iron-Oxide Nanoparticles for Transdermal Delivery: Cancer Therapy by Circumventing the Skin Barrier. Small 11:239–247. https://doi.org/10.1002/smll.201400775
Rosenberg SA, Yannelli JR, Yang JC, et al (1994) Treatment of Patients With Metastatic Melanoma With Autologous Tumor-Infiltrating Lymphocytes and Interleukin 2. JNCI J. Natl. Cancer Inst. 86:1159–1166
Ruifrok A, Johnston D (2001) Ruifrok AC, Johnston DA. Quantification of histochemical staining by color deconvolution. Anal Quant Cytol Histol 23: 291-299. Anal Quant Cytol Histol Int Acad Cytol Am Soc Cytol 23:291–9
Santini B, Zanoni I, Marzi R, et al (2015) Cream formulation impact on topical administration of engineered colloidal nanoparticles. PLoS One 10:e0126366
Sheth RA, Wen X, Li J, et al (2020) Doxorubicin-loaded hollow gold nanospheres for dual photothermal ablation and chemoembolization therapy. Cancer Nanotechnol 11:6. https://doi.org/10.1186/s12645-020-00062-8
Shubayev VI, Pisanic TR, Jin S (2009) Magnetic nanoparticles for theragnostics. Adv. Drug Deliv. Rev. 61:467–477
Tang J-Q, Hou X-Y, Yang C-S, et al (2017) Recent developments in nanomedicine for melanoma treatment. Int J Cancer 141:646–653. https://doi.org/10.1002/ijc.30708
Tomayko MM, Reynolds CP (1989) Determination of subcutaneous tumor size in athymic (nude) mice. Cancer Chemother Pharmacol 24:148–154. https://doi.org/10.1007/BF00300234
Vanella V, Festino L, Trojaniello C, et al (2019) The Role of BRAF-Targeted Therapy for Advanced Melanoma in the Immunotherapy Era. Curr Oncol Rep 21:76. https://doi.org/10.1007/s11912-019-0827-x
Vannucci L, Falvo E, Fornara M, et al (2012) Selective targeting of melanoma by PEG-masked protein-based multifunctional nanoparticles. Int J Nanomedicine 7:1489–509
Veiseh O, Gunn JW, Zhang M (2010) Design and fabrication of magnetic nanoparticles for targeted drug delivery and imaging. Adv. Drug Deliv. Rev. 62:284–304
Wang F, Wang YC, Dou S, et al (2011) Doxorubicin-tethered responsive gold nanoparticles facilitate intracellular drug delivery for overcoming multidrug resistance in cancer cells. ACS Nano 5:3679–92
Wang M, Marepally SK, Vemula PK, Xu C (2016) Chapter 5 - Inorganic Nanoparticles for Transdermal Drug Delivery and Topical Application. Nanosci. Dermatol. 57–72
Weiss RB (1992) The anthracyclines: will we ever find a better doxorubicin? Semin Oncol 19:670–86
Yu M, Jambhrunkar S, Thorn P, et al (2013) Hyaluronic acid modified mesoporous silica nanoparticles for targeted drug delivery to CD44-overexpressing cancer cells. Nanoscale 5:178–83
Zvyagin AV, Zhao X, Gierden A, et al (2008) Imaging of zinc oxide nanoparticle penetration in human skin in vitro and in vivo. J Biomed Opt 13:064031